
The tool uses a smartphone camera, a small 3D-printed box and a simple chemical test to show whether a dead mosquito belongs to the Aedes aegypti species. Vivian Abagiu
A new diagnostic tool has been developed by researchers at The University of Texas at Austin that can easily, quickly and cheaply identify whether a mosquito belongs to the species that carries dangerous diseases such as Zika virus, dengue, chikungunya or yellow fever. It can also determine whether the bug has come into contact with a mosquito-control strategy known as Wolbachia.
“Many of these diseases are spreading in areas where they weren’t common before,” said Sanchita Bhadra, a research associate in the Department of Molecular Biosciences and first author on the paper. “Having surveillance is important in conjunction with any kind of outbreak, and this method allows a rapid test in the field.”
The tool uses a smartphone camera, a small 3D-printed box and a simple chemical test to show whether a dead mosquito belongs to the Aedes aegypti species. Aedes aegypti carries Zika and other devastating viruses that afflict an estimated 100 million people worldwide each year. The species also is closely linked to the tripling of cases of mosquito-borne diseases in the United States since 2004.
The research appears in the journal PLOS Neglected Tropical Diseases.
The tool developed by scientists and students at UT Austin also detects the presence of a biopesticide called Wolbachia, a type of bacteria that keeps mosquitoes from spreading diseases. In countries around the world and in 20 U.S. states where the Aedes aegypti mosquito is found, scientists working in public health agencies have started to infect mosquitoes with Wolbachia by introducing the bacteria into a local mosquito population to help curb transmission of viruses.
Because mosquitoes show no outward signs of having the bacteria – and because existing diagnostic tests are hard to read, expensive and logistically cumbersome – the new tool represents a significant step forward for those hoping to monitor the effectiveness of Wolbachia.
“This test can happen without involving a lot of staff and equipment to make sure Wolbachia is effective and spreading as anticipated,” Bhadra said.
Public health groups trap and kill mosquitoes routinely in conjunction with monitoring efforts, but existing technology requires a complex process to extract nucleic acid from inside mosquitoes, often after they have been dead for days and have started to decay, leading to greater expense and the possibility of more errors in lab tests than the new technology.
The new diagnostic tool uses a smartphone’s camera and a simple test that can be done anywhere. It tests mosquitoes’ nucleic acid without requiring a complicated process to remove it. Officially known as a loop-mediated isothermal amplification and oligonucleotide strand displacement, or LAMP OSD, the probe delivers a simple yes-or-no readout on a cellphone, with accuracy of greater than 97 percent.
In addition to the tests to detect mosquito species and Wolbachia, the team also is exploring use of the technology to easily identify whether trapped mosquitoes are carrying Zika, dengue and other pathogens.
Learn more: Simple Test Detects Disease-Carrying Mosquitoes, Presence of Biopesticide
The Latest on: Disease diagnostic tool
via Google News
The Latest on: Disease diagnostic tool
- Tiny structures generate powerful beams for enhanced optical imagingon January 20, 2021 at 5:58 am
Even the smallest molecule can tell a big story. For instance, observing a single molecule can throw light on underlying biological processes in the human body. In fact, molecular imaging ...
- In-vitro Diagnostics (IVD) Market to Reach $118.5 Billion by 2027--Exclusive Report Covering Preon January 20, 2021 at 4:30 am
According to a new market research report, titled "In-vitro Diagnostics Market by Product & Solution (Consumables, Systems, Software ...
- Lyme Disease Research and Advocacy: The Pandemic Does Not Slow Them Downon January 20, 2021 at 1:53 am
Lyme disease research and advocacy efforts forged ahead and made some exciting advances in 2020 despite a pandemic that presented numerous challenges, delays and roadblocks in many areas of medical ...
- Hypothetical case suggests genetic testing has significant limitations for predicting disease in a healthy patienton January 19, 2021 at 12:35 am
Despite its utility as a diagnostic tool in patients with specific risk factors for genetic disease, genetic testing still has significant limitations for predicting disease in a healthy patient.
- Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Size, Share to Grow Momentously By 2023on January 18, 2021 at 10:12 am
The report titled "Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market: Size, Trends and Forecasts (2019-2023)", provides an in depth analysis of the global infectious ...
- Biomed Diagnostics is Ramping Up Production of InTray GC® to Fight Neisseria Gonorrhoeae Threaton January 18, 2021 at 5:24 am
Biomed Diagnostics has increased production of the InTray GC ® due to the shortages in STI testing supplies. The CDC recommends culture testing in tandem with NAAT testing, due to the dramatic ...
- CES 2021 MedFluid Develops First-In-Class Microfluidic Platform for Rapid Detection and Screening of Disease Diagnosison January 17, 2021 at 2:13 pm
TAIPEI, Taiwan, Jan. 17, 2021 /PRNewswire/ -- Health and Biotech company MedFluid has developed the fastest, first-in-class antimicrobial susceptibility test that will aid in providing precise medical ...
- The body's own signaling system provides the key to new diagnostic tools and personalized medicineon January 15, 2021 at 6:26 am
Several studies have demonstrated that tiny biological particles called exosomes may carry important information about diseases. We are currently searching for these tiny particles in cooperation with ...
- Researchers demonstrate great potential for blood test to detect, monitor Alzheimer's diseaseon January 14, 2021 at 9:08 am
In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for ...
- New studies support blood test for early detection of Alzheimer's diseaseon January 13, 2021 at 6:50 am
In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for ...
via Bing News